AdvaMedDx: Thierry Bernard, Norman Schwartz

AdvaMedDx has named Qiagen CEO Thierry Bernard as chairperson of the board of directors, succeeding Bio-Rad Laboratories CEO Norman Schwartz. AdvaMed represents more than 75 manufacturers of in vitro diagnostic tests and technologies in the US and abroad. Bernard joined Qiagen in 2015 and has served as CEO since 2019. He previously held executive positions at BioMérieux.